Search

everythinglearnresearchcommunity

for

Search:↓

The substances improved hair regrowth and protected hair cells in humans and mice.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Triptolide effectively and safely reduces actinic keratosis lesions in mice.

The developed nasal gel improves cilostazol delivery to the brain, enhancing its effectiveness and reducing side effects.

Compounds 6f and 6g effectively stop prostate cancer cell growth without harming healthy cells.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Prostasin has two roles in skin: one for normal skin development without needing activation, and another for proper hair growth that requires activation.

Nanoparticles can effectively deliver spironolactone to hair follicles for treating alopecia and acne.

Topical clobetasol propionate 0.05% ointment is more effective in promoting hair regrowth in patients with alopecia areata than topical tacrolimus 0.1% ointment.

Deltsid 7.5 is the most effective treatment for bovine psoroptosis.

A new treatment using nanoliposomes can improve hair regrowth in androgenetic alopecia.

The new synthetic retinoid RO 13-6298 effectively treated severe psoriasis at low doses with manageable side effects.

The microneedle patches effectively treat allergic conjunctivitis with controlled, sustained release of medication.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

Clascoterone is a promising topical treatment for hair loss and acne with fewer side effects.

Combining calcipotriol with mometasone is more effective for treating alopecia areata than using mometasone alone.

Topical methotrexate is more effective and as safe as betamethasone for treating alopecia areata.

Retinol acetate can reduce the harmful effects of the drug benoxaprofen on white blood cells.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

The use of Diane-35 and its generics significantly decreased in the Netherlands.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.